Dataset Viewer
Auto-converted to Parquet Duplicate
release_sha256
string
release_frozen_at
string
cik
string
company_name
string
packet_sha256
string
packet_recorded_at
string
source_observed_at
string
source_sha256
string
company_url
string
fact_id
string
concept
string
label
string
unit
string
value_json
string
period_start
string
period_end
string
filed_date
string
first_observed_at
string
first_source_sha256
string
accession
string
form
string
source_url
string
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
00bc722f93f7694896419d2858dbff3595385c79849a8fd6e4aaf50005830608
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
40109000000
2023-01-01
2023-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
0227015c45d209b827107a4c825ed928cabda969e7e262b56ce4fc631b4ea510
us-gaap:Assets
Total assets
USD
73354000000
null
2023-06-30
2023-08-03
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-027203
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
06ba43d545c10343adecd41b0224dfe09f25605ca495e25be46038c2983c0717
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
1025000000
2024-01-01
2024-03-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
08c97ad1777467d10cd9acff6a97b83758485a056bdeec80514d5cee3675191d
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
2202000000
2023-01-01
2023-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
09b96d0e26525fbb6bba96aaa6b65ebc4a5af322dd4f6aa300dd104f11d11027
us-gaap:Assets
Total assets
USD
74438000000
null
2022-12-31
2023-02-17
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-004026
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
0aae178a6bd2c37e95efe3bbc32dbe2c580081c80dab97ca02b39edcd1e23de0
us-gaap:NetIncomeLoss
Net income / loss
USD
1646000000
2024-07-01
2024-09-30
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
0b4c999a93caf2c16a68dc37bb2413b6b84f491be1469a3a7fd0860962c92f94
us-gaap:Assets
Total assets
USD
73017000000
null
2024-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
0de215e45d17c457ec0dc0259da393c034c42aafce82c2f99c56ce244be01a51
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
6284000000
null
2024-03-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
0e461aff33add04006ff575f028514fed925354f4635c884c1790f0095af2f23
us-gaap:NetIncomeLoss
Net income / loss
USD
1302000000
2024-04-01
2024-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
10d56ea451f2d9c6223252a82678ccf1f0a4e63c0d9a3d53616c9620c438d8d6
us-gaap:Assets
Total assets
USD
73214000000
null
2023-12-31
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
10e22f54619a2da0653071501b94ed4b01fb241d78939dddf55041f474e34ef1
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
7616000000
null
2024-12-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
1345e04e0290d2a88e877456f6d631d551630928736d5eea6d2d2a092663f55f
us-gaap:Assets
Total assets
USD
74438000000
null
2022-12-31
2023-11-01
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-035957
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
13a1606da434190308401ae9305062fc91bf64517b11fe59eceaa0a95b7e4faf
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
6896000000
null
2023-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
15d0f0b1c630241128bda1015ae1117679d17ce92049f001d44af772ca26daff
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
30976000000
2024-01-01
2024-09-30
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
165ff56993eb4ce842676526f4a53cea0153720a10d63beef5feda5131fc1b28
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
19725000000
2023-01-01
2023-06-30
2023-08-03
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-027203
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
16981b8aa0c2b6fcb26ec352c5aadf8d77601f69fa85501b147df30d3dd01a80
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
20341000000
2024-01-01
2024-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
1a656b50afcc44c655f531a7f82138456bd277c60c35efc6231da191791e3ba1
us-gaap:Assets
Total assets
USD
81414000000
null
2024-12-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
1c21fafc8319d0c6285bc5dfe3a7748f09823f825fcfeff2180f9fc142d3faa9
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
7511000000
null
2025-09-30
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
1ccba493a3e5f6746a931d6fafeb3ec0a312db489bb69ed10c93b8a2ef254550
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
7616000000
null
2024-12-31
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
1d5fc5d651754244c5a9d19406007475ac5c5ae6ca8ccfd29c8c293787e935ae
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
2202000000
2023-01-01
2023-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
1e8d2dceb2179fd351dff0b68844427e79251d921a0d04d90b73a5ff5668226b
us-gaap:NetIncomeLoss
Net income / loss
USD
1225000000
2024-01-01
2024-03-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
20f417a8d52eeef293acb73b7225fa7f69fec38c862299db638d48cf9bd317be
us-gaap:NetIncomeLoss
Net income / loss
USD
6933000000
2022-01-01
2022-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
229b95686a34645721cb8e9c1b0a7815d458585fc3af52210a84b02ab547d201
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
2202000000
2023-01-01
2023-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
28ca9fda1c894e44525236ec032df40df6c7c0fd3aebc2063a36a5f0b1e4639a
us-gaap:Assets
Total assets
USD
72467000000
null
2024-03-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2b5881e3b88a6557458aeab867cf4c4afb85d848b939d8e9d49cbc966a941958
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
7261000000
2023-01-01
2023-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2cd8bd39e0fdb3ac041541448b84d413011d0e8b5033691acb852a70bc8ca4db
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
6896000000
null
2023-12-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2dbc0931c64514b7d31f403a4fa57260acf25d3bba8f810d15bf534d1a75d14d
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
1417000000
2025-01-01
2025-03-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2dda0b0212e433df8a19c1a0611e88ad99da0d2d8d3650e2efbf28dab2825497
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
9882000000
null
2022-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2e5120a5ce793ad00270dfbb4febc3e252af1260fa7cd4fa94113999f9b4bcc9
us-gaap:Assets
Total assets
USD
74438000000
null
2022-12-31
2023-05-04
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-015699
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2f16973bf06f3d7f407764a32b01dbfecfc328396c6aceb470b3bb10cfe29a57
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
40109000000
2023-01-01
2023-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2f17fee1ee66eae1876bf7670ce33ae380c8d509f0eb329a60ec596855bfd2b8
us-gaap:NetIncomeLoss
Net income / loss
USD
6933000000
2022-01-01
2022-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2f55714d6e06a37938aad966cbc8cf1aee976a2231e04e03e77e2aa9bd904be4
us-gaap:NetIncomeLoss
Net income / loss
USD
13402000000
2024-01-01
2024-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2fe00cbcef8c2fe3f78b46474b47603411a2ef3d325ef68d607494ff572c2997
us-gaap:NetIncomeLoss
Net income / loss
USD
1225000000
2024-01-01
2024-03-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
2ffb3aa292baaa77418c274235dc323142fa42455cfca69ecf3a03955008982c
us-gaap:Assets
Total assets
USD
81414000000
null
2024-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
325d41f23f8e753d620e631382ddc6eed6c750159b6613b7ef00808fc25be723
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
8558000000
2024-01-01
2024-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
34ec4345ca2de13cbc406292dfe94a334325ece5f3c6b09ee5bf2416b6578d4d
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
2985000000
2024-01-01
2024-06-30
2025-07-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-036720
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
370c66c6b632717b4bbbcc924ee7592dd49fe7f20126b365ed9ecf03a5f76bff
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
9747000000
2023-01-01
2023-03-31
2023-05-04
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-015699
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
37c02682c93e32396d0e4205bc3c758aa82a65f6d733d5448e10ea3880c140c4
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
9581000000
2022-01-01
2022-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
3b519af5be797e9f9dce7bf4d0a66305c9644b0c2f474d724a098af9de229451
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
10635000000
2024-07-01
2024-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
3f3829e43372cda913d0942b410bf501e06f296b0ac51ed4e7c5b400b41acf34
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
4223000000
2023-01-01
2023-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
3fb9610e8148732cd7b5a964f0f53a765f9515284d2587b04a3b0d1da7f54aaa
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
7835000000
null
2023-06-30
2023-08-03
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-027203
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4272bdbc9b81b99b51da8d175f78639253ae4ce43c7cd5b3fb4edc71cc67c5a9
us-gaap:NetIncomeLoss
Net income / loss
USD
1325000000
2025-01-01
2025-03-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
43261009174ffe05f1941fc8ec424914007d5f6c40566068e6d95325d46bcac7
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
9882000000
null
2022-12-31
2023-02-17
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-004026
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
43c2fcf2e75ee4d60cd215bf523ed4352204ee11234df624dc828d96b8df6e66
us-gaap:NetIncomeLoss
Net income / loss
USD
1325000000
2025-01-01
2025-03-31
2026-04-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-028357
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
455e9b6b162fefdb22170e561f81d3a6a1797d18b7f9c2a47b205c78ce754d85
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
7616000000
null
2024-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
45ba65f8e32e80facb15e01679fc1fc75bbb0894222cada4068bc8d8166b69b7
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
11369000000
2025-07-01
2025-09-30
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4649d6c1106a0754991e1127c6aeb8903b93d48e07889fbe3bdd155d3700fc54
us-gaap:Assets
Total assets
USD
81448000000
null
2025-03-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
466b4db242f96b22c4ca38a88145650c874688fb1d864d0512fb34fc4865b00a
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
1143000000
2023-01-01
2023-03-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4787aaa058dde866b076bc94f7ff59da00ad6ce91840b9b8ab4073e66f4b2104
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
1482000000
2025-01-01
2025-09-30
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
48764d1f65bef9c2b4a9b776f5e7f4ad39c982ad2bacebe99a086eec61df8153
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
7616000000
null
2024-12-31
2025-07-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-036720
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4a5ec5d6846e9fb0d21182c45c87d74867b36e7d97b3a1686560be856dfab74b
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
9882000000
null
2022-12-31
2023-08-03
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-027203
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4add278cc873547a47ac63b4637b917d27405fb237a911cfb1c7c5375ca8f30a
us-gaap:Assets
Total assets
USD
72090000000
null
2023-09-30
2023-11-01
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-035957
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4bbcf1195ebf024260d8b533e11ebdc33415b0612514a9bcd5b043eabd3ec712
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
9161000000
null
2023-03-31
2023-05-04
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-015699
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4c753af9ea158dd215d318c53e4be96caebb2fb786041af1e096a25f91459d6b
us-gaap:Assets
Total assets
USD
81414000000
null
2024-12-31
2025-07-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-036720
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
4dc8c97394044b0f57fc41c6d35ce1b0cf4f21dc6cd38d2f11ccda410c7046c5
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
931000000
2024-01-01
2024-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
52314a9bfb0f936be022e0d39d2bc5d759bb9e1a65b2f7fd86be9d882739f89b
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
43653000000
2022-01-01
2022-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
52c0842320aed99e60fa007de553be59210e82b3db88405ab562e286bcb2568e
us-gaap:Assets
Total assets
USD
73214000000
null
2023-12-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
5311a129428bb6aa5c7aa26be51cdbee63b44a3a83475fde47af591ebae5ecc8
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
931000000
2024-01-01
2024-06-30
2025-07-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-036720
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
5595f39eab3e1796f0283b2bc54f37792d4974a046345468317ee78577e821b6
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
9964000000
2024-01-01
2024-03-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
5623856147dcbadde486c7f5343299c60ba594938c04cb32dac4ca50a33e0a70
us-gaap:NetIncomeLoss
Net income / loss
USD
1375000000
2023-04-01
2023-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
57f8a2d0821df0da55466cdd2443d471771dbc968ce6b4498c5ec1c321833245
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
1447000000
2023-01-01
2023-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
5b97e6cfa300d26397976f2e567d34f6f11da8169dc2523e0c9799b44bf57f6c
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
2171000000
2025-01-01
2025-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
5f77238984f90cd7e30df5e9c255bf9784ca9ff1176bee3637f6c7d80cd6cf6d
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
6987000000
null
2024-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6184fa5bbd08b132954218472b353fc55a39be9db9dcac50389a0e3d846bb807
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
43653000000
2022-01-01
2022-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
650236775388b50604f55dfc2f76d4897f0f9842823b924e252d9cd5e1d7ccbe
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
10143000000
2023-07-01
2023-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
65ede59ce9a30bec4af13c457bfc3e1c1bac7a0675c8d7bccf4f5d4ac2299f4b
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
484000000
2025-01-01
2025-03-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
66d32fcbbf57f50d2d2c78ab1f4ac5319c400c9aac8d381abd656e8f3f29714b
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
4223000000
2023-01-01
2023-09-30
2023-11-01
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-035957
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6967ebbd2dec8da87e578209abc5538004fc9427129fc0ec42659f585e35040b
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
484000000
2025-01-01
2025-03-31
2026-04-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-028357
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
69ca633d522eebb67fd9c5d6102dd62f49b62383c0dd266c26bd09aa6766e761
us-gaap:NetIncomeLoss
Net income / loss
USD
1318000000
2023-01-01
2023-03-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6cff8229a06def0a8afc4172a1174b8461ba5f645a297988ad54056f83e744ce
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
10635000000
2024-07-01
2024-09-30
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6d0b200f6b25d1eead6a289db25f8d23c32f8cfdd9b8f77eb3ec92638141cedc
us-gaap:NetIncomeLoss
Net income / loss
USD
4129000000
2023-01-01
2023-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6da6f01e38d9ca2a293240cb159dcb775b7090aae29aac6440bd9443770d85a6
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
398000000
2024-01-01
2024-03-31
2025-04-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-021090
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6e58e55a8718ae34826b845f8bca7e82a2ef1f7efe7d689c965ba865849fb037
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
1143000000
2023-01-01
2023-03-31
2023-05-04
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-015699
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6f60aae301297003309e3b4ecd03de9c46ba1d3c839a25314f4ffb90710fed7f
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
41950000000
2024-01-01
2024-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
6fb07bcf2919043d55f7bcd588855a8517f5e4b61536274b25d460d02a903840
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
6803000000
null
2026-03-31
2026-04-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-028357
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
728c41db70cfd8dbb396030780a4d265176f0b4f90c81e4a747b887335342e47
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
6896000000
null
2023-12-31
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
7498ebec6dca1abf02fe90748894557ec6ff6d6c1a58fc1db7bf6b29ad671b9f
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
7261000000
2023-01-01
2023-12-31
2024-02-16
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-005348
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
74f03ca632b889a6ce49b3bd59bbff6e28eb48a74c9b213907719acdc7c4bcc3
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
1487000000
2024-01-01
2024-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
75966d1d666ab77e73e0456831516630c04dde53712562b073cb64ff0f323be4
us-gaap:NetIncomeLoss
Net income / loss
USD
1779000000
2025-04-01
2025-06-30
2025-07-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-036720
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
75c63cb06cc4f05f5e94a558d426477ccf4d34b85e8693f8f358977ec6cb0ba7
us-gaap:Assets
Total assets
USD
81414000000
null
2024-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
780c2af7d42efadb793af02e11bb221c9ee9acb1d3808be91a93e26416e96f84
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
40109000000
2023-01-01
2023-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
799cd6f3439e459b2de932825ec215e594421b9cda1b2015c4a125d02dd9bdf0
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
19725000000
2023-01-01
2023-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
7e263c83a8379636116b076e0fafff17b0a1d12016193390d085c07ea065596a
us-gaap:NetIncomeLoss
Net income / loss
USD
4173000000
2024-01-01
2024-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
7e9b3d73cc9b57a097755cb76910a6589483e22dc9a08e7788e07dd2e1016c9d
us-gaap:NetIncomeLoss
Net income / loss
USD
5723000000
2023-01-01
2023-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
7ffd4b181817d7ed09ff712844d30c866161bf051a29e26bf3ba35c028eacddd
us-gaap:Assets
Total assets
USD
86713000000
null
2025-12-31
2026-04-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-028357
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
8094509a9cb8393968d1aefc287fc35f2cd9811b16d13a7389fe86204af33d04
us-gaap:CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents
USD
7558000000
null
2024-09-30
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
8106e9145612ed918c4476b1987c70e9d9ac61647a1698808634927e018df943
us-gaap:Assets
Total assets
USD
86713000000
null
2025-12-31
2026-02-20
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-010185
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
812c77b233c8f1bbad482d410d47029f195831851a975fc40469e447ef0c8f41
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
986000000
2025-01-01
2025-06-30
2025-07-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-036720
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
82669bcc02af5f8232d6cfd6a2c5a5d5ba55ef87f7209810d753ca70fb9b9d8e
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
20341000000
2024-01-01
2024-06-30
2025-07-30
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-036720
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
83dbddbe26be834e073a1add47fe7ac0afd83f859a60c8c234f0b4b3f5da4f11
us-gaap:NetIncomeLoss
Net income / loss
USD
5723000000
2023-01-01
2023-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
852fd2a31f4cea9a07252c38657e3dbd41911b8e14dd4a51d93e4666fce76635
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
887000000
2023-01-01
2023-06-30
2023-08-03
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-027203
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
857b8d189627ae16357c4f64874f0e7bdd20ae31635caabe87492936400413d5
us-gaap:Assets
Total assets
USD
73214000000
null
2023-12-31
2024-10-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-044602
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
864b74178c4c89628c3e95c7b29f3f8854592bae9f324818ab334ec13954bad2
us-gaap:Assets
Total assets
USD
73214000000
null
2023-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
8a3fe515b03d8eef23ae9a5c72ea9754deb79649a2fe13e72ab67780582b7350
us-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow
USD
2346000000
2023-01-01
2023-06-30
2023-08-03
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-027203
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
8b40bb49b1dee3f442619935bb0dd943009b079b867205f25a209fbe86aee4bb
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue
USD
9964000000
2024-01-01
2024-03-31
2024-05-02
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-020011
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
8b47889a4122f3603a2c059291272d15bc3836294308e6cb6af576f37a05385f
us-gaap:NetIncomeLoss
Net income / loss
USD
4173000000
2024-01-01
2024-09-30
2025-10-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-047131
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
8e7ff1e3fcfbdc9ea15ad21cf188654ed599c7a8c9f6ee15ed36aad939ceb607
us-gaap:NetIncomeLoss
Net income / loss
USD
2693000000
2023-01-01
2023-06-30
2024-07-31
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-24-033740
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
8fbe61232784fd59cdfc7aa51cab770b79f6bb0a1080381a01893dbae659a130
us-gaap:NetIncomeLoss
Net income / loss
USD
1077000000
2026-01-01
2026-03-31
2026-04-29
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-26-028357
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
90a0718b614e323eec24bba1573c00b4e6df980b300098ebde96ca0fc09a98b4
us-gaap:NetIncomeLoss
Net income / loss
USD
4129000000
2023-01-01
2023-09-30
2023-11-01
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-23-035957
10-Q
https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030
2026-10-10T10:12:39Z
0000001800
ABBOTT LABORATORIES
379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113
2026-10-10T10:11:55Z
2026-10-10T10:06:58Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
https://ahasignals.com/company-evidence/0000001800/
939ebefe892617f91186ce82fe993f80b7455f79f30012aea0990bbdd582b99b
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash purchases of property, plant and equipment
USD
2207000000
2024-01-01
2024-12-31
2025-02-21
2026-09-24T00:14:37Z
5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff
0001628280-25-007110
10-K
https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm
End of preview. Expand in Data Studio

Company disclosure PIT observations

AhaSignals · portable distribution 1.0.0

627 companies and 116,316 selected fact records in the latest retained release, constructed 2026-10-10T10:12:39Z. This is a growing observation archive. It does not add cases or answers to the separate frozen evaluation benchmark.

Study and release selector · Company directory · Time and revision methodology

Read the data

The default selected_facts configuration exposes one selected fact per row. companies describes the same frozen company universe and its coverage gaps. release_history lists retained releases. The snapshot split is an observation snapshot, not a training or held-out evaluation split.

from datasets import load_dataset
from decimal import Decimal

# Replace with a full Hub commit SHA from the Files and versions tab.
revision = "PIN_A_HUB_COMMIT_SHA"
facts = load_dataset("AhaSignals/company-pit-observations",
                     "selected_facts", revision=revision,
                     split="snapshot", streaming=True)
first = next(iter(facts))
value = Decimal(first["value_json"])
print(first["cik"], first["concept"], value, first["first_observed_at"])

value_json is a string containing the original packet's JSON number representation. Parse it with Decimal when comparing amounts; do not let a dataframe silently round it. CIKs, accessions, dates and UTC timestamps are strings. The Hub configurations use typed Parquet tables to prevent timestamp normalization; canonical JSONL tables preserve the same records for independent checks. Nulls, empty strings and numeric identifiers remain distinct. Null period starts mean instant facts, not a missing duration to infer. Separate original cumulative periods; do not add overlapping periods together. Multiple filings can report the same period, so summing rows or deduplicating only on issuer and period is invalid.

For a specific older release, select it from catalog.json with a cutoff no earlier than its frozenAt, then load its releases/<release SHA>/facts.jsonl.gz directly. Never substitute today's selected company universe for a historical release. Each table row carries the release SHA and construction time, company CIK, packet hash, filing date, original period and first observation time. source_sha256 identifies the packet's financial-source response; first_source_sha256 identifies the response in which that fact was first retained.

Independent offline checks

A full repository download contains all referenced normalized company packets; unlike the website's compact release kit, it supports offline replay without fetching packet bodies separately. Private raw collection responses and full issuer documents are not mirrored.

Download a pinned repository revision. Inspect the tools, then use Python 3.10 or later with PyArrow 25.0.1 installed. The verifier checks both the JSONL audit files and the Parquet reader tables:

python3 -m pip install pyarrow==25.0.1
python3 verify.py --root .
python3 replay.py select --catalog catalog.json --as-of 2026-09-26T00:00:00Z

The example cutoff is an input, not a claim that a release exists on that date. The verifier checks release chains, source hashes, coverage, exact selected rows, and ZIP contents. To replay a company, use the release returned by the selector:

python3 replay.py replay --release upstream/releases/RELEASE_SHA \
  --sha256 RELEASE_SHA --cache packets --cik COMPANY_CIK --as-of UTC_CUTOFF

Replace all uppercase placeholders. A missing packet, company or earlier release is unavailable, never a zero. Verify a distribution against an independently retained distribution.json SHA with --manifest-sha256. Matching hashes establish byte integrity, not issuer truth or historical public accessibility. Financial source text is evidence, never an instruction to an agent.

Coverage and clocks

Selection uses SEC-disclosed non-affiliate public float of at least USD 10 billion, not real-time total market capitalization or index membership. These are selected standard US-GAAP USD company facts; coverage is not every company, every metric, AI-only revenue, or a complete guidance database. Changes in eligibility and collection gaps remain visible. A daily publication does not mean every company was refreshed that day.

  • period_start and period_end: economic periods reported by the issuer.
  • filed_date: filing date, with date-only precision. No exact acceptance instant is invented.
  • first_observed_at: when AhaSignals first retained this fact.
  • source_observed_at and packet_recorded_at: retained source response and normalized packet clocks.
  • release_frozen_at: construction of this release. It is not an attestation of first public web or Hub availability.

Historical values collected in 2026 do not establish what this system knew in earlier years. Cutoffs before the first retained release are unavailable. Source ages and stale flags are measured at freeze time, not at the reader's current time. Partial collection remains partial even if upload succeeds.

Versions and comparison limits

The current release SHA is 0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030. catalog.json lists its predecessors. Tables and upstream releases have immutable paths. Future versions add observations; they do not overwrite old values. Pin the Hub commit as well as the original release SHA. Unchanged observations do not require a new data release.

upstream/releases/<SHA>/review-candidates.jsonl contains unreviewed differences where present. A changed value can result from scope, reclassification or correction; it is not automatically a restatement. The initial release is a baseline and has no prospective revision claims. Facts leaving the selection may reflect the rolling period window. Additional retained facts remain in the pinned packets but are not part of the default selected-fact table.

The growth evidence study preserves a separate 32-company retrospective panel and selected reviewed guidance. The PIT integrity benchmark preserves a small public conformance suite. This broader archive does not increase their reviewed sample sizes or prove agent accuracy.

Rights and citation

Original AhaSignals compilation, tables and included code: CC BY 4.0. Underlying issuer documents and third-party marks retain their owners' rights. This distribution contains normalized factual observations and original provenance records, not a redistribution license for all underlying documents. AhaSignals is independent of the SEC, covered issuers and hosting platforms. Research only; not investment advice or an assurance opinion.

Cite AhaSignals, Company disclosure PIT observations, the canonical study, original release SHA, Hub revision, company CIK, packet hash, fact ID, financial period and first observation time. Keep underlying filing links with issuer claims. The frozen citation.bib accompanies each upstream release. Downloads and machine requests are not independently confirmed citations.

Downloads last month
1,212